Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

HY21 result: How are Serko (ASX:SKO) shares travelling?

Serko Ltd (ASX: SKO) has reported its FY21 half year result to 30 September 2020. It’s suffering because of COVID-19.

What did Serko report?

The online travel booking and expense management business said that its six-month travel booking volumes were down 77%. However, the company pointed out that October volumes were ‘only’ down 35%.

Total operating revenue was $5.1 million, down 66% because of COVID-19. ‘Recurring’ product revenue was $4.6 million, down from $13.3 million. Half year total income was $8.5 million, down from $15.2 million.

The percentage of transactions occurring on its Zeno platform continued to increase, it represented 38% of online transactions in September, up from 25% at the end of March 2020.

Serko reported EBITDAF (EBITDA explained – the F stands for foreign currency) for the period was a loss of $6.7 million compared to a profit of $1.4 million in the prior corresponding period.

The travel business said it generated a loss after tax of $10.1 million, which was a steep decline from the net loss of $0.9 million last year. Lower revenue and investing for growth in anticipation of a travel recovery combined for the disappointing result.

In terms of its net cash burn, it averaged $1.8 million per month over the half year.

The company finished with a cash balance of $31.5 million. After the recent capital raising it has over $90 million of cash on hand.

Serko Chair Claudia Batten said: “Amid this disruption our travel management company (TMC) resellers and partners recognise the pivotal role Serko’s solutions and relationships can play in managing the disruption and preparing for the recovery. Many have requested accelerated timetables to onboard new customers, deliver new features and expand existing partnerships, while many others are considering or are planning to follow suit.”

Summary thoughts

The travel industry could be one of the last to see a share price recovery, but that could mean that it’s an opportunity during these times, though Serko has recovered back to its pre-COVID-19 price. If the vaccines from Moderna and BioNTech are as good as it initially seems, them Serko could be a higher-risk buying opportunity today.

However, there are other ASX growth shares that I’d prefer as a recovery idea like EML Payments Ltd (ASX: EML).

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content